Literature DB >> 21287985

Synthesis of docosasaccharide arabinan motif of mycobacterial cell wall.

Akihiro Ishiwata1, Yukishige Ito.   

Abstract

Mycobacterial arabinan is a common constituent of both arabinogalactan (AG) and lipoarabinomannan (LAM). In this study, synthesis of β-Araf containing common arabinan docosasaccharide motif (22 Araf monomer units) of mycobacterial cell wall was achieved. Our synthetic strategy toward arabinan involves (1) the stereoselective β-arabinofuranosylation using both 3,5-O-TIPDS-protected and NAP-protected arabinofuranosyl donors for straightforward intermolecular glycosylation and intramolecular aglycon delivery (IAD), respectively, and (2) the convergent fragment coupling with branched fragments at the linear sequence using thioglycoside donor obtained from the corresponding acetonide at the reducing terminal of each fragment through a three-step procedure. Because the acetonide at the reducing terminal of all fragments would be converted to thioglycoside as the glycosyl donor, and mainly Bn ether protections were used, our strategy will be readily applicable to the synthesis of more complex arabinan, arabinogalactan, and arabinomycolate derived from mycobacterial CWS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21287985     DOI: 10.1021/ja109932t

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  12 in total

Review 1.  Automated Chemical Oligosaccharide Synthesis: Novel Approach to Traditional Challenges.

Authors:  Matteo Panza; Salvatore G Pistorio; Keith J Stine; Alexei V Demchenko
Journal:  Chem Rev       Date:  2018-06-28       Impact factor: 60.622

2.  Synthetic arabinomannan glycolipids impede mycobacterial growth, sliding motility and biofilm structure.

Authors:  Kirtimaan Syal; Krishnagopal Maiti; Kottari Naresh; Prakash Gouda Avaji; Dipankar Chatterji; Narayanaswamy Jayaraman
Journal:  Glycoconj J       Date:  2016-06-04       Impact factor: 2.916

3.  Nucleophilic addition to silyl-protected five-membered ring oxocarbenium ions governed by stereoelectronic effects.

Authors:  Vi Tuong Tran; K A Woerpel
Journal:  J Org Chem       Date:  2013-06-24       Impact factor: 4.354

Review 4.  Chemical Synthesis of Cell Wall Constituents of Mycobacterium tuberculosis.

Authors:  Mira Holzheimer; Jeffrey Buter; Adriaan J Minnaard
Journal:  Chem Rev       Date:  2021-06-30       Impact factor: 60.622

5.  [Au]/[Ag]-catalysed expedient synthesis of branched heneicosafuranosyl arabinogalactan motif of Mycobacterium tuberculosis cell wall.

Authors:  Shivaji A Thadke; Bijoyananda Mishra; Maidul Islam; Sandip Pasari; Sujit Manmode; Boddu Venkateswara Rao; Mahesh Neralkar; Ganesh P Shinde; Gulab Walke; Srinivas Hotha
Journal:  Nat Commun       Date:  2017-01-25       Impact factor: 14.919

6.  Total synthesis of mycobacterial arabinogalactan containing 92 monosaccharide units.

Authors:  Yong Wu; De-Cai Xiong; Si-Cong Chen; Yong-Shi Wang; Xin-Shan Ye
Journal:  Nat Commun       Date:  2017-03-16       Impact factor: 14.919

Review 7.  Intramolecular glycosylation.

Authors:  Xiao G Jia; Alexei V Demchenko
Journal:  Beilstein J Org Chem       Date:  2017-09-29       Impact factor: 2.883

8.  Total synthesis of Lentinus giganteus glycans with antitumor activities via stereoselective α-glycosylation and orthogonal one-pot glycosylation strategies.

Authors:  Yunqin Zhang; Yanlei Hu; Shanshan Liu; Haiqing He; Roujing Sun; Gang Lu; Guozhi Xiao
Journal:  Chem Sci       Date:  2022-05-27       Impact factor: 9.969

9.  Protection against Experimental Melioidosis with a Synthetic manno-Heptopyranose Hexasaccharide Glycoconjugate.

Authors:  Andrew E Scott; William J Christ; Alison J George; Margaret G M Stokes; Gregory J S Lohman; Yuhong Guo; Matthew Jones; Richard W Titball; Timothy P Atkins; A Stewart Campbell; Joann L Prior
Journal:  Bioconjug Chem       Date:  2016-05-17       Impact factor: 4.774

10.  Twenty Years of Mycobacterial Glycans: Furanosides and Beyond.

Authors:  Todd L Lowary
Journal:  Acc Chem Res       Date:  2016-06-13       Impact factor: 22.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.